A new analysis of publicly reported financial information of the pharmaceutical industry finds reducing drug prices could have no impact to future drug approvals.
Aug 12, 2021
0
2
Just weeks before the first COVID-19 cases emerged, Gallup published its latest poll on America's views about business. At the bottom of the list of 25 sectors was the pharmaceutical industry. Below advertising. Below oil ...
Aug 4, 2021
0
1
The United States will purchase 200 million more COVID-19 vaccine doses from Pfizer and BioNTech and has an option to buy additional doses to address virus variants, the companies announced Friday.
Jul 23, 2021
0
2
A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.
Jul 21, 2021
0
236
UK policymakers preparing trade deals post-Brexit can learn important lessons from New Zealand's 'unique drug agency' the Pharmaceutical Management Agency (PHARMAC), if prices for therapies and access to key drugs are to ...
Jul 19, 2021
0
1
The mRNA vaccines for COVID-19, made by Pfizer/BioNTech and Moderna, are among the most powerful vaccines the world has ever seen. According to clinical trial data, they are more than 94% effective at preventing symptomatic ...
Jul 14, 2021
1
582
Juul, the leading e-cigarette maker in the United States, has agreed to pay $40 million to settle a lawsuit by North Carolina that alleged the company intentionally got scores of teenagers hooked on nicotine.
Jun 28, 2021
0
3
The latest setback for Johnson & Johnson's COVID-19 vaccine was the U.S. Food and Drug Administration's order on June 11, 2021, to discard 60 million doses that failed to meet quality and safety guidelines. A Baltimore manufacturing ...
Jun 24, 2021
0
1
Argenx, a Belgium pharmaceutical company, recently announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living ...
Jun 18, 2021
0
3
Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led to increases in list prices and out-of-pockets costs for ...
Jun 15, 2021
0
4
